Search results
Showing 121 to 135 of 1215 results for pain
for chronic primary pain: What is the clinical and cost effectiveness of psychodynamic psychotherapy for managing chronic primary...
Burosumab for treating X-linked hypophosphataemia in children and young people (HST8)
Evidence-based recommendations on burosumab (Crysvita) for X-linked hypophosphataemia in children and young people.
Recommendation ID CG143/1 Question Pain management for patients with an acute painful sickle cell episode:- For patients with an acute
This guideline sets out an antimicrobial prescribing strategy for adults with leg ulcer infection. It aims to optimise antibiotic use and reduce antibiotic resistance.
therapies for chronic primary pain: What is the clinical and cost effectiveness of manual therapy for managing chronic primary...
therapy for chronic primary pain: What is the clinical and cost effectiveness of relaxation therapies for managing chronic primary...
therapy for chronic primary pain: What is the clinical and cost effectiveness of laser therapy for managing chronic primary...
In development Reference number: GID-TA11817 Expected publication date: 09 July 2026
This quality standard covers diagnosing and managing acute coronary syndromes in adults (aged 18 and over). Acute coronary syndromes are medical emergencies that include myocardial infarction (heart attack) and unstable angina (unexpected, severe chest pain). It describes high-quality care in priority areas for improvement.
View quality statements for QS68Show all sections
Sections for QS68
- Quality statements
- Quality statement 1: Diagnosis of acute myocardial infarction
- Quality statement 2: Risk assessment for adults with NSTEMI or unstable angina
- Quality statement 3: Coronary angiography and PCI within 72 hours for NSTEMI or unstable angina
- Quality statement 4: Coronary angiography and PCI for adults with NSTEMI or unstable angina who are clinically unstable
- Quality statement 5: Level of consciousness and eligibility for coronary angiography and primary PCI
- Quality statement 6: Primary PCI for acute STEMI
- Update information
Relugolix–estradiol–norethisterone for treating symptoms of endometriosis (TA1057)
Evidence-based recommendations on relugolix–estradiol–norethisterone (Ryeqo) for treating symptoms of endometriosis in adults of reproductive age.
Show all sections
Recommendation ID NG41/1 Question Neuropathic pain relief:- Does early treatment with a centrally acting analgesic (for example...
Evidence-based recommendations on denosumab (XGEVA) for the prevention of skeletal-related events in adults with bone metastases from solid tumours.
dose of a single administration of gabapentin to relieve pain in people undergoing surgery whose pain is expected to be...
Is there a potential for dependence associated with pharmacological agents for neuropathic pain?
neuropathic pain? Any explanatory notes(if applicable) There has been some suggestion that some pharmacological agents for neuropathic...
Question Monotherapy versus combination therapy for treating neuropathic pain:- What is the clinical effectiveness, cost effectiveness...